NuProject’s Post

Last week, NCIA co-chair Michael Cooper spoke on behalf of the legal cannabis industry during an event convened by the The National Academies of Sciences, Engineering, and Medicine for the purpose of informing their future policy recommendations for the industry. Our members make it possible for Main Street Cannabis to consistently have a seat at the table at important conversations such as this one. Dive into the details on Marijuana Moment: https://bit.ly/3NbDNNW #CannabisIndustry #PolicyInfluence #EngageWithExperts

We eagerly anticipate the implementation of these changes and are dedicated to supporting both our valued clients and the broader industry throughout this transition. Stay tuned for more updates as we navigate this exciting journey together! 🚀 #FairRegulations #IndustryAdvocacy #Cannabis #CannabisRescheduling #EndTheStigma #CannabisPolicy #CannabisLegislation

With a robust medical program and infrastructure serving 400K+ patients, #Pennsylvania is well-positioned to operate a strong adult-use market. It’s estimated that medical cannabis sales alone were around $1.5B in 2023, beating BDSA’s initial estimate of ~$1.2B. The sheer size of the medical market has ranked PA 7th in the top 10 U.S. cannabis job markets (Vangst) and has already created 28K+ jobs (Pennsylvania Cannabis Coalition). With over two-thirds of PA voters in support of legalization, I’m hopeful lawmakers can agree on a framework and take advantage of what could be a massively successful market. https://lnkd.in/eA3fbvMv #CannabisMarket #CannabisIndustry #CannabisLegislation

We are thrilled that the federal government has taken a monumental step forward by moving to reclassify cannabis from Schedule I to Schedule III. This significant decision marks a pivotal moment for the cannabis industry, consumers, patients, and investors alike. Reclassifying cannabis to Schedule III opens up new possibilities for research, innovation, and accessibility. Patients will have greater access to cannabis-derived medications, while consumers can expect expanded options and increased quality standards. Investors, who have been eagerly awaiting this development, now have a clearer path to navigate and explore opportunities in the cannabis market. At The White Oak Bridge, we applaud this progressive move and are excited about the positive impact it will have on the industry as a whole. We believe that this reclassification will pave the way for continued growth, innovation, and investment in the cannabis sector. If you've been waiting for the right moment to explore investment opportunities in the cannabis industry, now is the time to start the conversation. Reach out to us today to learn more about how you can be part of this exciting journey. Let's embrace this historic moment together and usher in a new era of possibilities for cannabis! #CannabisReclassification #InvestmentOpportunities #NewEraOfPossibilities 🌱

Another political gimmick or a real change in the Cannabis Industry? Thoughts on the DEA's reclassification of cannabis? With over 67 years of combined experience, the SAX LLP practice group, Sax Cannabis Advisors led by Todd Polyniak, is and has been at the forefront of navigating the evolving landscape of the cannabis industry. If you are a recent licensee, have an established cannabis business or are contemplating becoming an active participant, please reach out to explore how Sax Cannabis Advisors can help you attain and maintain your success! #saxllp #saxcannabisadvisors #saxwa #financialplanning #taxstrategies #regulations #cannabis https://lnkd.in/eTXrZYFs Visit: https://lnkd.in/ejuptWzY

With recent reports that the U.S. Drug Enforcement Administration intends to reschedule marijuana, operators feel tremendous anticipation for significant, near-term cannabis industry reforms. Whether it is rescheduling, the adult-use ballot initiative in Florida, recreational sales in Ohio or advancement of the SAFER Banking Act, the cannabis industry is buzzing with excitement for important catalysts to come to fruition – and rightfully so. While caught up in discussions about the next big announcement, the cannabis industry has overlooked the impressive work marijuana operators did in 2023 to improve operating performance and efficiency. For many companies, this progress established their ability to survive and even thrive in a world without incremental reform. Read about 2023 highpoints - https://lnkd.in/gH2xAfCW

The Biden administration's move to reclassify marijuana as a less dangerous drug is huge news for the budding weed industry, Axios' Emily Peck, Felix Salmon and Dan Primack write. Why it matters: The industry has been held back by the drug's squishy legal status. Shares of Canopy Growth — one of the largest publicly traded cannabis companies — rose 82% yesterday on the news. 💡 How it works: Though dozens of states have legalized or decriminalized marijuana, at the federal level it's classified as Schedule 1 — drugs with high potential for abuse and no medical use. That's made it difficult for the industry to operate across state lines and access banking services. It also means cannabis companies can't deduct business expenses on their federal taxes. The result: Profit margins are low.

"With the evolving landscape around cannabis legislation, the Biden administration has made a significant move by advocating for the rescheduling of marijuana. This initiative aims to address the shifting public sentiment and respond to the demand for updated regulations. While opinions may differ on the science and process, it's undeniable that change is on the horizon. As discussions continue, it's essential to stay informed and engage in meaningful dialogue to shape policies that balance public health, safety, and societal expectations. The future of cannabis legislation may soon look very different." Let's discuss how AMOS can position your cannabis business for success in any environment: https://zurl.co/XjC5

Reflecting on the second Monday of 2024, where discussions on marijuana legalization continue to evolve. Governor DeSantis acknowledges the importance of states' autonomy in deciding their stance on cannabis. How do you believe this dynamic between federal and state perspectives will shape the future of the cannabis industry? Share your insights and let's engage in a thoughtful debate on the changing landscape of cannabis policy. #CannabisLegalization #StateAutonomy #DeSantis https://lnkd.in/edHetUhG

Let's talk about what rescheduling from I to III really means to your business. Taking the time to work through different strategies now will be time well spent in preparation for what's to come. Book some time with us: https://lnkd.in/gfPXqe7x #cannabis #efficiency #strategicplanning #increaseprofits